Literature DB >> 17505035

Cystic lung disease in Birt-Hogg-Dube syndrome.

Dereje S Ayo1, Gregory L Aughenbaugh, Eunhee S Yi, Jennifer L Hand, Jay H Ryu.   

Abstract

BACKGROUND: To describe the clinical, radiologic, and histopathologic aspects of cystic lung disease occurring in patients with Birt-Hogg-Dubé (BHD) syndrome, a rare, inheritable, multisystem disorder.
METHODS: We retrospectively reviewed five patients with BHD syndrome evaluated at the Mayo Clinic Rochester from 1998 through 2005.
RESULTS: Mean age (+/- SD) at the time of pulmonary evaluation was 56.4 +/- 4.8 years; four patients were men. Three patients had not received a diagnosis of BHD syndrome at the time of initial CT of the chest. Three patients had a smoking history, and two were nonsmokers. Two patients had a history of recurrent pneumothoraces. Pulmonary function tests available in four patients revealed normal results in one patient and mild airflow obstruction or nonspecific pattern of abnormalities in three patients. CT of the chest revealed cystic lung disease in all five patients; cysts were round to oval in shape, ranged widely in size, and were randomly distributed throughout the lungs, except for a predilection to involve the lung bases more extensively. Three patients with a smoking history had more severe cystic changes compared to nonsmokers and included both patients with recurrent pneumothoraces. Surgical lung biopsy available in one patient revealed emphysema-like changes. Follow-up CT scans available in four patients revealed relative stability over a median interval of 20 months (range, 3 to 66 months).
CONCLUSION: We conclude that cystic lung disease in BHD syndrome varies widely in severity, mimics pulmonary lymphangioleiomyomatosis, and may be worsened by smoking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505035     DOI: 10.1378/chest.07-0042

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  23 in total

Review 1.  Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 2.  The three R's of lung health and disease: repair, remodeling, and regeneration.

Authors:  Michael F Beers; Edward E Morrisey
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 3.  Lymphangioleiomyomatosis: what do we know and what are we looking for?

Authors:  S Harari; O Torre; J Moss
Journal:  Eur Respir Rev       Date:  2011-03

4.  Pleural Covering Application for Recurrent Pneumothorax in a Patient with Birt-Hogg-Dubé Syndrome.

Authors:  Hiroki Ebana; Mizuto Otsuji; Teruaki Mizobuchi; Masatoshi Kurihara; Kazuhisa Takahashi; Kuniaki Seyama
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-09-11       Impact factor: 1.520

5.  Loss of FLCN inhibits canonical WNT signaling via TFE3.

Authors:  John C Kennedy; Damir Khabibullin; Thomas Hougard; Julie Nijmeh; Wei Shi; Elizabeth P Henske
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

6.  Cystic lung disease in birt-hogg-dubé syndrome: a case series of three patients.

Authors:  Abidin Kilincer; Orhan Macit Ariyurek; Nevzat Karabulut
Journal:  Eurasian J Med       Date:  2014-06

Review 7.  Pulmonary manifestations of Birt-Hogg-Dubé syndrome.

Authors:  Nishant Gupta; Kuniaki Seyama; Francis X McCormack
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 8.  Diffuse cystic lung diseases.

Authors:  Jay H Ryu; Xinlun Tian; Misbah Baqir; Kaifeng Xu
Journal:  Front Med       Date:  2013-05-11       Impact factor: 4.592

9.  Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Expert Opin Orphan Drugs       Date:  2014-11-29       Impact factor: 0.694

10.  A de novo FLCN mutation in a patient with spontaneous pneumothorax and renal cancer; a clinical and molecular evaluation.

Authors:  Fred H Menko; Paul C Johannesma; R Jeroen A van Moorselaar; Rinze Reinhard; Jan Hein van Waesberghe; Erik Thunnissen; Arjan C Houweling; Edward M Leter; Quinten Waisfisz; Martijn B van Doorn; Theo M Starink; Pieter E Postmus; Barry J Coull; Maurice A M van Steensel; Johan J P Gille
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.